This protocol must be read in its entirety before using Catalog # NSC002 and AR003.
Caution: The mouse cortical stem cells used in this protocol contain trace amounts of human transferrin and DMSO, and the media used in this protocol contains trace amounts of transferrin. The transferrin was tested at the donor level using an FDA licensed method and found to be non-reactive for anti HIV-1/2 and Hepatitis B surface antigen. Because no testing can offer complete assurance of freedom from infectious agents, these reagents should be handled as if capable of transmitting infection.
Note: Sterile technique is required when handling the reagents.
Component | Amount |
DMEM/F12 | 6 g |
Glucose | 0.775 g |
Glutamine | 0.0365 g |
NaHCO3 | 0.845 g |
N-2 Plus Media Supplement | 5 mL |
Review the following protocol in detail before thawing the cells.
Use serological pipettes to transfer and remove solutions.
Figure 1: A. Undifferentiated mouse cortical stem cells cultured on poly-L-ornithine and fibronectin coated dishes. B - D. Mouse cortical stem cells differentiated for 7 days. Neuronal lineage cells (B) were detected with mouse anti-neuron specific beta III tubulin (R&D Systems, Catalog # MAB1195) followed by NorthernLights™ 557-conjugated donkey anti-mouse IgG (R&D Systems, Catalog # NL007); astrocyte lineage cells (C) were detected with sheep anti-human GFAP (R&D Systems, Catalog # AF2594) followed by NorthernLights 557-conjugated donkey anti-sheep IgG (R&D Systems, Catalog # NL010); and oligodendrocyte lineage cells (D) were detected with mouse anti-oligodendrocyte marker O4 (R&D Systems, Catalog # MAB1326) followed by Rhodamine Red®-conjugated goat anti-mouse IgM. Image A is shown at 100X. Images B, C, and D are shown at 200X. Rhodamine Red is a trademark of Invitrogen. |